Changes in the perioperative management and outcomes of patients with upper tract urothelial carcinoma undergoing radical nephroureterectomy at Memorial Sloan Kettering Cancer Center: Over 20 years of experience Journal Article
| Authors: | Yip, W.; Assel, M. J.; Wong, N. C.; Tracey, A. T.; Alvim, R. G.; Nogueira, L.; Almassi, N.; Singla, N.; Clinton, T. N.; Sjoberg, D. D.; Al-Ahmadie, H.; Hakimi, A. A.; Pietzak, E. J.; Cha, E. K.; Donahue, T. F.; Dalbagni, G.; Bochner, B. H.; Bajorin, D. F.; Coleman, J. A. |
| Article Title: | Changes in the perioperative management and outcomes of patients with upper tract urothelial carcinoma undergoing radical nephroureterectomy at Memorial Sloan Kettering Cancer Center: Over 20 years of experience |
| Abstract: | Introduction: We evaluated surgical trends, perioperative management evolution, and oncologic outcomes in patients who underwent radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC) at a tertiary cancer center over a 24-year period. Methods: Between 1995 and 2018, we evaluated 743 consecutive patients with UTUC who underwent RNU. Generalized additive models were used to estimate the associations between date of surgery and continuous outcomes using a linear model, dichotomous outcomes using a logit link, categorical outcomes using multinomial models, and 2- and 5-year survival outcomes using Cox proportional hazards models. Results: Over the study period, preoperative diagnostic endoscopic biopsies increased from 10% to 66%, along with the proportion of patients who underwent RNU for high-grade disease from 55% to 91%. The rate of open RNU declined from 100% to 56% with a rise in minimally invasive approaches. Median lymph node yield increased with more retroperitoneal lymph node dissections performed. Neoadjuvant chemotherapy utilization increased with a contemporary utilization rate of 32%, coinciding with an increase in pT0 rate from 2% to 8%. Cancer-specific survival probabilities improved over the study period, while metastasis-free and overall survival remained stable. Conclusions: We found several changes in treatment patterns and outcomes for patients with UTUC over the past 2 decades. How individual alterations in management factors, such as patient selection, perioperative chemotherapy, lymphadenectomy, and salvage therapies, impact patient outcomes is challenging in the setting of multiple overlapping practice changes for this rare disease and warrants further investigation. © 2024 Lippincott Williams and Wilkins. All rights reserved. |
| Keywords: | adult; cancer chemotherapy; human tissue; treatment outcome; aged; major clinical study; overall survival; salvage therapy; patient selection; follow up; lymph node dissection; cancer center; length of stay; cancer specific survival; urothelial carcinoma; nephroureterectomy; surgery; upper tract urothelial carcinoma; neoadjuvant chemotherapy; endoscopic biopsy; perioperative chemotherapy; transitional cell carcinoma; outcomes; perioperative care; radical nephroureterectomy; human; male; female; article; perioperative management; multidisciplinary team |
| Journal Title: | Urology Practice |
| Volume: | 11 |
| Issue: | 2 |
| ISSN: | 2352-0779 |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2024-03-01 |
| Start Page: | 356 |
| End Page: | 366 |
| Language: | English |
| DOI: | 10.1097/upj.0000000000000507 |
| PROVIDER: | scopus |
| PUBMED: | 38315829 |
| PMCID: | PMC11323897 |
| DOI/URL: | |
| Notes: | The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PDF. Corresponding MSK author is Jonathan A. Coleman -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work